Company intelligence / Profile preview

Oncoscope-AI

Chicago, Illinois, United Statesoncoscope-ai.com ↗

Ownership: Private
Development stage: Commercial

Overview

Oncoscope-AI offers an AI-driven clinical decision-support platform that conducts daily Cochrane-level reviews of oncology literature. It extracts key variables from publications, integrates them with treatment guidelines and regulatory/clinical trial data, and delivers real-time evidence-based insights to oncologists. The system aims to improve patient outcomes by enabling timely, informed treatment decisions. All extracted data are human-reviewed for accuracy before integration into the database.

Therapeutic areas: Oncology
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Oncoscope-AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oncoscope-AI.

Explore the full profile